Podcast: focus on contraception

0.5 CPD hoursIn this episode of the MIMS Learning Clinical Update podcast, contraception expert Professor John Guillebaud explains why he believes the 7-day contraceptive pill break should be consigned to history. It also features a case-based discussion on complex contraception scenarios and provides three key points on prescribing emergency contraception.You can visit the website version of this podcast on MIMS Learning to make notes for your appraisal. MIMS Learning offers hundreds of hours of CPD for healthcare professionals, along with a handy CPD organiser.Please note: this podcast is presented by medical editors and discusses educational content written or presented by doctors, nurses and other healthcare professionals on the MIMS Learning website and at live events.Complex contraceptionMIMS Learning. Contraception: the basics. March 2023.MIMS Learning. Complex contraception scenarios part 1. March 2023MIMS Learning. Complex contraception scenarios part 2. March 2023Best use of hormonal contraceptionMIMS Learning. Best use of oral hormonal contraception. November 2023.Li RHW, Tsing Lo SS, Gemzell-Danielsson K. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet 2023; 402: 851–8.Turok DK, Gero A, Simmons RG. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception. N Engl J Med 2021; 384: 335–44.Akintomide H, Barnes P, Brima N and Mansour D. Higher discontinuation rate with a standard-sized compared to a small-sized 'gold standard' copper intrauterine device: a case-control review. BMJ Sex Reprod Healt 2019. doi: 10.1136/bmjsrh-2018-200296.Emergency contraceptionMIMS Learning. Choices in emergency contraception. Last updated October 2023.MIMS Learning. Answering patients' questions on intrauterine contraception. November 2020.Register to access contentRegister for a free MIMS Learning healthcare professional account Hosted on Acast. See acast.com/privacy for more information.

There are no comments yet.

Please log in to write the first comment.